PAVmed (PAVM) Operating Leases (2022 - 2026)

PAVmed has reported Operating Leases for 5 years, with the latest figure at $2.0 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 21.59% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $2.0 million, a 21.59% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 18.55% from the prior year.
• Operating Leases was $2.0 million for Q2 2026 at PAVmed, down from $2.2 million in the prior quarter.
• The five-year high for Operating Leases was $6.0 million in Q2 2024, with the low at $2.0 million in Q2 2026.
• Average Operating Leases over 5 years is $3.4 million, with a median of $3.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Operating Leases surged 74.44% in 2023, then slumped 58.4% in 2025.
• Over 5 years, Operating Leases stood at $3.0 million in 2022, then jumped by 51.49% to $4.5 million in 2023, then tumbled by 39.01% to $2.8 million in 2024, then fell by 18.55% to $2.2 million in 2025, then retreated by 12.46% to $2.0 million in 2026.
• The last three Operating Leases figures came in at $2.0 million (Q2 2026), $2.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.